184 related articles for article (PubMed ID: 24434284)
1. DNA damage response (DDR) via NKX3.1 expression in prostate cells.
Erbaykent-Tepedelen B; Karamil S; Gonen-Korkmaz C; Korkmaz KS
J Steroid Biochem Mol Biol; 2014 May; 141():26-36. PubMed ID: 24434284
[TBL] [Abstract][Full Text] [Related]
2. NKX3.1 contributes to S phase entry and regulates DNA damage response (DDR) in prostate cancer cell lines.
Erbaykent-Tepedelen B; Ozmen B; Varisli L; Gonen-Korkmaz C; Debelec-Butuner B; Muhammed Syed H; Yilmazer-Cakmak O; Korkmaz KS
Biochem Biophys Res Commun; 2011 Oct; 414(1):123-8. PubMed ID: 21945437
[TBL] [Abstract][Full Text] [Related]
3. NKX3.1 activates cellular response to DNA damage.
Bowen C; Gelmann EP
Cancer Res; 2010 Apr; 70(8):3089-97. PubMed ID: 20395202
[TBL] [Abstract][Full Text] [Related]
4. Rac1 protein signaling is required for DNA damage response stimulated by topoisomerase II poisons.
Huelsenbeck SC; Schorr A; Roos WP; Huelsenbeck J; Henninger C; Kaina B; Fritz G
J Biol Chem; 2012 Nov; 287(46):38590-9. PubMed ID: 23012366
[TBL] [Abstract][Full Text] [Related]
5. Expression profile of an androgen regulated prostate specific homeobox gene NKX3.1 in primary prostate cancer.
Xu LL; Srikantan V; Sesterhenn IA; Augustus M; Dean R; Moul JW; Carter KC; Srivastava S
J Urol; 2000 Mar; 163(3):972-9. PubMed ID: 10688034
[TBL] [Abstract][Full Text] [Related]
6. Functional activation of ATM by the prostate cancer suppressor NKX3.1.
Bowen C; Ju JH; Lee JH; Paull TT; Gelmann EP
Cell Rep; 2013 Aug; 4(3):516-29. PubMed ID: 23890999
[TBL] [Abstract][Full Text] [Related]
7. Assessment of ATM phosphorylation on Ser-1981 induced by DNA topoisomerase I and II inhibitors in relation to Ser-139-histone H2AX phosphorylation, cell cycle phase, and apoptosis.
Kurose A; Tanaka T; Huang X; Halicka HD; Traganos F; Dai W; Darzynkiewicz Z
Cytometry A; 2005 Nov; 68(1):1-9. PubMed ID: 16184611
[TBL] [Abstract][Full Text] [Related]
8. DNA-PKcs plays a dominant role in the regulation of H2AX phosphorylation in response to DNA damage and cell cycle progression.
An J; Huang YC; Xu QZ; Zhou LJ; Shang ZF; Huang B; Wang Y; Liu XD; Wu DC; Zhou PK
BMC Mol Biol; 2010 Mar; 11():18. PubMed ID: 20205745
[TBL] [Abstract][Full Text] [Related]
9. Structural and functional interactions of the prostate cancer suppressor protein NKX3.1 with topoisomerase I.
Song LN; Bowen C; Gelmann EP
Biochem J; 2013 Jul; 453(1):125-36. PubMed ID: 23557481
[TBL] [Abstract][Full Text] [Related]
10. Testosterone promotes DNA damage response under oxidative stress in prostate cancer cell lines.
Ide H; Lu Y; Yu J; China T; Kumamoto T; Koseki T; Yamaguchi R; Muto S; Horie S
Prostate; 2012 Sep; 72(13):1407-11. PubMed ID: 22290195
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of ATM blocks the etoposide-induced DNA damage response and apoptosis of resting human T cells.
Korwek Z; Sewastianik T; Bielak-Zmijewska A; Mosieniak G; Alster O; Moreno-Villanueva M; Burkle A; Sikora E
DNA Repair (Amst); 2012 Nov; 11(11):864-73. PubMed ID: 23058634
[TBL] [Abstract][Full Text] [Related]
12. Loss of H3K9me3 Correlates with ATM Activation and Histone H2AX Phosphorylation Deficiencies in Hutchinson-Gilford Progeria Syndrome.
Zhang H; Sun L; Wang K; Wu D; Trappio M; Witting C; Cao K
PLoS One; 2016; 11(12):e0167454. PubMed ID: 27907109
[TBL] [Abstract][Full Text] [Related]
13. DNA damage recognition via activated ATM and p53 pathway in nonproliferating human prostate tissue.
Jäämaa S; Af Hällström TM; Sankila A; Rantanen V; Koistinen H; Stenman UH; Zhang Z; Yang Z; De Marzo AM; Taari K; Ruutu M; Andersson LC; Laiho M
Cancer Res; 2010 Nov; 70(21):8630-41. PubMed ID: 20978201
[TBL] [Abstract][Full Text] [Related]
14. Most hydrogen peroxide-induced histone H2AX phosphorylation is mediated by ATR and is not dependent on DNA double-strand breaks.
Katsube T; Mori M; Tsuji H; Shiomi T; Wang B; Liu Q; Nenoi M; Onoda M
J Biochem; 2014 Aug; 156(2):85-95. PubMed ID: 24682951
[TBL] [Abstract][Full Text] [Related]
15. Benzo[a]pyrene induces complex H2AX phosphorylation patterns by multiple kinases including ATM, ATR, and DNA-PK.
Yan C; Lu J; Zhang G; Gan T; Zeng Q; Shao Z; Duerksen-Hughes PJ; Yang J
Toxicol In Vitro; 2011 Feb; 25(1):91-9. PubMed ID: 20888899
[TBL] [Abstract][Full Text] [Related]
16. BMI1 attenuates etoposide-induced G2/M checkpoints via reducing ATM activation.
Wei F; Ojo D; Lin X; Wong N; He L; Yan J; Xu S; Major P; Tang D
Oncogene; 2015 Jun; 34(23):3063-75. PubMed ID: 25088203
[TBL] [Abstract][Full Text] [Related]
17. Functional analysis of NKX3.1 in LNCaP prostate cancer cells by RNA interference.
Possner M; Heuser M; Kaulfuss S; Scharf JG; Schulz W; Hermann-Ringert R; Thelen P
Int J Oncol; 2008 Apr; 32(4):877-84. PubMed ID: 18360715
[TBL] [Abstract][Full Text] [Related]
18. Reptin regulates DNA double strand breaks repair in human hepatocellular carcinoma.
Raymond AA; Benhamouche S; Neaud V; Di Martino J; Javary J; Rosenbaum J
PLoS One; 2015; 10(4):e0123333. PubMed ID: 25875766
[TBL] [Abstract][Full Text] [Related]
19. Evidence for the direct binding of phosphorylated p53 to sites of DNA breaks in vivo.
Al Rashid ST; Dellaire G; Cuddihy A; Jalali F; Vaid M; Coackley C; Folkard M; Xu Y; Chen BP; Chen DJ; Lilge L; Prise KM; Bazett Jones DP; Bristow RG
Cancer Res; 2005 Dec; 65(23):10810-21. PubMed ID: 16322227
[TBL] [Abstract][Full Text] [Related]
20. Both ERK1 and ERK2 kinases promote G2/M arrest in etoposide-treated MCF7 cells by facilitating ATM activation.
Wei F; Xie Y; Tao L; Tang D
Cell Signal; 2010 Nov; 22(11):1783-9. PubMed ID: 20637859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
